The business combination of European Biotech Acquisition Corp. (EBAC/W/U) and Oculis SA closed on Thursday, March 2, 2023. As a result of the business combination, the common stock, warrant, and unit of European Biotech Acquisition Corp. (EBAC/W/U) will be suspended from trading. The suspension details are as follows:
| Company Name/Issue: |
European Biotech Acquisition Corp. Class A Ordinary Shares |
| CUSIP#: |
G3167F102 |
| Symbol: |
EBAC |
| Last Trading Date: |
March 2, 2023 |
| Marketplace Effective Date for Suspension: |
March 3, 2023 |
| Merger Consideration: |
One (1) Oculis Holding AG Ordinary Share (OCS) for each share held.
|
| Company Name/Issue: |
European Biotech Acquisition Corp. Warrant |
| CUSIP#: |
G3167F128 |
| Symbol: |
EBACW |
| Last Trading Date: |
March 2, 2023 |
| Marketplace Effective Date for Suspension: |
March 3, 2023 |
| Merger Consideration: |
One (1) Oculis Holding AG Warrant (OCSAW) for each warrant held.
|
| Company Name/Issue: |
European Biotech Acquisition Corp. Unit |
| CUSIP#: |
G3167F110 |
| Symbol: |
EBACU |
| Last Trading Date: |
March 2, 2023 |
| Marketplace Effective Date for Suspension: |
March 3, 2023 |
| Merger Consideration: |
Unit will separate into its components. |
As a result of the merger the combined company will be listed on the Nasdaq Global Market. The details are as follows:
| Company: |
Oculis Holding AG Ordinary Share
|
| CUSIP#: |
H5870P102
|
| Symbol: |
OCS |
| Marketplace Effective Date: |
March 3, 2023
|
| Company: |
Oculis Holding AG Warrant expiring 3/2/2028
|
| CUSIP#: |
H5870P110
|
| Symbol: |
OCSAW |
| Marketplace Effective Date: |
March 3, 2023
|
If you would like to register as a market maker in OCS & OCSAW, contact Nasdaq Trading Services at +1 212 231 5100.
RSS Feeds
Product Login
